NFKB1 and Sepsis: Our previous research showed that iPSC-CM reduces NF-κB activity [5] and neutrophil chemotaxis [6] by inhibiting the expression of triggering receptors expressed on myeloid cells 1 and p38 mitogen-activated protein kinase signaling [7] in sepsis-induced ALI.